Papa John's International

In its 2021 Corporate Responsibility (CR) report, Papa John’s International provided a granular breakdown by weight of its top purchased items. The company has scored lower this year as it has not provided an updated breakdown for any of its purchased animal proteins outside of cheese, since 2021. In its 2024 CR report, the company states it purchased 118 million pounds of cheese in 2024. Papa John's menu items include pizza toppings such as bacon, meatballs, pepperoni and steak as well as items such as fiery buffalo chicken and chicken wings. Eggs are listed as an ingredient in some of its menu items, and the company has a commitment to transition to 100% cage-free eggs by 2030. It could be helpful to investors to see a new breakdown of its top purchased items, in a manner similar to its 2021 reporting to understand the company's current exposure to each animal protein. In its 2024 update of its Implementation of its Core Animal Welfare Commitments, published by Papa John’s (GB) Ltd the company identifies chicken, beef, pork and milk as core ingredients and egg as a non-core ingredient. It does not provide a percentage or volume breakdown of exposure to each animal protein.

In Papa Johns 2024 CR report, the company states that it has sourced its chicken pizza toppings and chicken poppers in the US from supply chains that use no antibiotics important to human medicine (NAIHM) since 2021. In 2021, the company had to transition away from the no antibiotics ever policy it implemented in 2016 due to supply chain issues. It is unclear if the company’s definition of NAIHM aligns with the latest list of medically important antibiotics from the WHO published in 2024. Papa John’s International does not provide evidence that it has an antibiotic policy in place for its beef, pork, egg-layers, and dairy or that it is currently engaging its supply chains related to this. It is unclear if it has exposure to farmed seafood such as anchovies. Papa John’s GB Ltd has a separate animal welfare and antibiotics policy in place for its restaurants covering broilers, beef, pork, dairy, and egg layers. It stipulates two commitments related to antibiotics. The first is to ensure that antibiotics are not used for growth promotion, and the second is to end the reliance on antibiotics to support poor production systems by avoiding the routine prophylactic and metaphylactic use of antibiotics and by limiting the use of CIAs. Papa John’s GB Ltd continues to report that it is in compliance with its commitment to prohibit the use of antibiotics for growth promotion in its broilers that are sourced from Europe and UK, where growth promotion is banned, as well as from Thailand where its farm assurance schemes verify antibiotics are not used for this purpose. Its pork, dairy, beef and eggs are all also sourced from the EU and UK. EU regulation restricts prophylactic and metaphylactic use to exceptional circumstances, and the company states that its farm assurance schemes provide additional independent verification that routine prophylactic and metaphylactic use is avoided. The company reports it is not able to deliver on its commitments to limit the use of CIAs as this is not consistently monitored across its various farm assurance schemes.

In its 2024 CR report, the company states that its US grilled chicken toppings and boneless chicken wings are sourced from supply chains that do not use antibiotics important to human medicine. The company's US operations make up approximately 49% of its global operations. In its 2024 Annual Report, the company reports that it has approximately 450 restaurants in the UK. If the, Papa John’s GB Ltd policy to ensure that antibiotics are not used for growth promotion, to avoid the use of antibiotics for prophylaxis and metaphylaxis, and to restrict the use of critically important antibiotics, covers all UK its restaurants this policy would apply to approximately 7.5% of the company's restaurants.

Papa Johns states that its grilled chicken pizza toppings and boneless wings are sourced from supply chains that do not use antibiotics important to human medicine, suggesting it is tracking antibiotic use but the company does not disclose antibiotic use data. Papa John’s GB Ltd uses independent verification that antibiotics are not being used for growth promotion routine prophylactic and metaphylactic use in its chicken, pigs, dairy cows, beef cattle and laying hens but does not disclose antibiotic use data.

Papa John’s International does not provide evidence of a third party auditing its US supply chains for antibiotic use in its public disclosures. Papa John’s GB Ltd animal welfare commitments continue to be covered by five farm assurance schemes: Red Tractor, Bord Bia, QS, IKB-KIP, and FARM FIRST. These provide third-party verification that its antibiotics are not being used for growth promotion, prophylactic use or routine metaphylactic use.

Papa John’s International does not disclose evidence of a non-compliance procedure for its antibiotic use. Papa John’s GB Ltd reports that incidences of non-compliance with its Animal Welfare Commitments will be reported to the Regional QA who will coordinate a root cause analysis and log corrective actions. It also reports on non-compliance with its core animal welfare commitments in its ‘Implementation of our Core Animal Welfare Commitments' document.

Papa John’s International does not disclose evidence of a forward-looking antibiotic reduction target aligned with the WHO Guidelines for proteins or locations where it does not have an existing policy.

This is not applicable as the company does not disclose forward-looking antibiotic reduction targets.

This is not applicable as the company does not disclose forward-looking antibiotic reduction targets.